Patient Resources

AstraZeneca has been committed to the fight against breast cancer for over 30 years—and is equally committed to supporting breast cancer patients. The programs below are for women with breast cancer and the people who care about them. They offer opportunities and resources for learning, sharing, and coping with breast cancer.

Patients currently undergoing therapy for breast cancer may find the following consumer sites of interest and helpful as their course of treatment proceeds.

The following list of resources is provided solely as a convenience. AstraZeneca takes no responsibility for the content of, or services provided by, these resources, and makes no representations as to the accuracy or completeness of any information provided. AstraZeneca shall have no liability for any damages or injuries of any kind arising from the information provided.

American Cancer Society 1180 Avenue of the Americas, Floor 6
New York, NY 10036
Phone: 800-227-2345

BreastCancer.org 7 East Lancaster Ave.
3rd Floor
Ardmore, PA 19003

Breast Cancer Network of Strength 135 S. LaSalle St., Suite 2000
Chicago, IL 60603
Phone: 312-986-8338

CancerCare 275 Seventh Avenue, Floor 22
New York, NY 10001
Phone: 212-712-8400 or 800-813-4673

Centers for Disease Control and Prevention Office of Program and Policy Information
National Center for Chronic Disease, Prevention and Health Promotion
Division of Cancer Prevention and Control
4770 Buford Highway, NE
Mail Stop K-64
Atlanta, GA 30341
Phone: 800-CDC-INFO

National Cancer Institute NCI Public Inquiries Office
6116 Executive Boulevard
Suite 300
Bethesda, MD 20892-8322
Phone: 800-4CANCER (800-422-6237)

OncoLink Abramson Cancer Center of the University of Pennsylvania
3400 Spruce Street, 2 Donner
Philadelphia, PA 19104

Oncology Nursing Society 125 Enterprise Drive
Pittsburgh, PA 15275
Phone: 866-257-4ONS or 412-859-6100
Toll-free fax: 877-369-5497

Prevent Cancer Foundation 1600 Duke Street, Suite 500
Alexandria, VA 22314
Phone: 703-836-4412 or 800-227-2732

Susan G. Komen for the Cure 5005 LBJ Freeway, Suite 250
Dallas, TX 75244
Phone: 972-855-1600 or 877-GO-KOMEN (877-465-6636)

The National Breast Cancer Coalition 1101 17th Street, NW, Suite 1300
Washington, DC 20036
Phone: 800-622-2838 or 202-296-7477

FASLODEX is indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

IMPORTANT SAFETY INFORMATION:
FASLODEX is contraindicated in patients with known hypersensitivity to the drug or to any of its components. Hypersensitivity reactions, including urticaria and angioedema have been reported in association with FASLODEX.

Click Here for Additional Safety Information

OnCue - News for
oncology professionals

Regularly updated articles cover a range of topics including treatment information, oncology conferences details, and patient resources.

Visit OnCueFeed.com
HCP Request for Representative

Get Connected

Request to have an AstraZeneca representative contact you.

Request a Rep